Handelsavisen
prelaunch
Companies Financials HBMN.S
HB
HBMN.S Investment Management & Fund Operators

HBM Healthcare Investments AG

$251,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,19 %
Op margin
47,2 %
ROE
1,1 %
Net margin
44,1 %
Debt / equity
0,06
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

HBM Healthcare Investments AG is an investment management company that primarily invests in the healthcare sector, generating revenue through capital appreciation and dividend income from its portfolio of healthcare-related assets.

Business. HBM Healthcare Investments AG (HBMN.S) is an investment management and fund operator headquartered in Switzerland. The company operates within the Banking & Investment Services sector, generating revenue primarily through fee-based models associated with asset management. Specific details regarding operating segments and geographic breakdowns are not available. The firm is listed under the ticker HBMN.S.

Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryInvestment Management & Fund Operators
ActivityBanking & Investment Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
1,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning HBMN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HBMN.S. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    HBM Healthcare Investments AG (HBMN.S) is an investment management and fund operator headquartered in Switzerland. The company operates within the Banking & Investment Services sector, generating revenue primarily through fee-based models associated with asset management. Specific details regarding operating segments and geographic breakdowns are not available. The firm is listed under the ticker HBMN.S.

    Classification92 %
    SectorFinancials
    Business sectorBanking & Investment Services
    IndustryInvestment Management & Fund Operators
    ActivityBanking & Investment Services
    AI synthesis
    GENERATED

    HBM Healthcare Investments AG maintains a capital structure with a low debt-to-equity ratio of 0.06, indicating a conservative leverage profile. However, the company's liquidity position is assessed as medium, with a current ratio of 0.81, suggesting that its current liabilities exceed its current assets. The negative net cash position, after subtracting total debt, further highlights potential liquidity constraints.

    In terms of profitability, the company's return on equity (ROE) is 1.13%, and its return on assets (ROA) is 1.06%, both of which are below the typical thresholds for strong performance in the investment management industry. These figures suggest that the company is generating modest returns relative to its equity and asset base.

    The company's revenue is concentrated in the healthcare sector, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as regulatory changes or market volatility in the healthcare industry.

    Looking at the growth trajectory, the company's recent financial performance shows a net income of CHF 18.54 million, but its operating cash flow is negative at CHF -2.36 million. This discrepancy may indicate that the company is reinvesting in its operations or facing temporary cash flow challenges. The outlook for the current fiscal year is not explicitly provided, but the negative operating cash flow suggests caution in forecasting near-term growth.

    The risk assessment indicates a low potential for dilution, with no significant dilution sources identified in the provided data. However, the company's liquidity risk is moderate, primarily due to its negative net cash position and low current ratio. Credit risk is not explicitly quantified, but the low leverage profile suggests a relatively stable credit position.

    Recent events, such as filings and transcripts, are not detailed in the provided data. However, the company's financial snapshot indicates a need for careful monitoring of its liquidity and cash flow management to ensure long-term stability.

    Key takeaways
    • HBM Healthcare Investments AG has a conservative capital structure with a low debt-to-equity ratio of 0.06.
    • The company's return on equity and return on assets are below typical performance thresholds for the investment management industry.
    • Revenue is concentrated in the healthcare sector, with no geographic diversification disclosed.
    • The company's liquidity position is medium, with a current ratio of 0.81 and a negative net cash position.
    • There is a low potential for dilution, but liquidity risk remains a concern due to the negative operating cash flow.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $251,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.65B
    Net cash
    -$97.1M
    Current ratio
    0.8
    Debt / equity
    0.1
    ROA
    1.1%
    ROE
    1.1%
    Cash conversion
    -13.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy1
    Buy0
    Hold0
    Sell0
    Strong sell0
    12-month price target$280,00 · Median $280,00
    Low $280,00High $280,00

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin47,2 %Above median
    Net Margin44,1 %Above median
    ROE1,1 %Below median
    D/E0,06Below median
    Cash Conv-0,13Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • HBM Healthcare Investments AG Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HBMN.SCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage